Shares of Netherlands-based Orthofix International N.V. (OFIX), a diversified global medical device company focused on developing and delivering innovative orthopedic solutions, have seen precipitous drop in price due to some company-specific issues and an unusual decline in Q1, 2013 gross margin. Currently the shares are trading around $20, near four-year lows.
Orthofix has a robust balance sheet, a unique product portfolio and a new management team, which I believe will help the company to stage a turnaround as early as next year. I believe that the correction offers an excellent investing opportunity for the medium-term with ~60% upside potential.
Orthofix is a diversified medical device company focused on developing and delivering innovative orthopedic solutions for patients,...
Only subscribers can access this article, which is part of the PRO research library covering 3,587 different stocks.
Growing numbers of fund managers and other investment professionals subscribe to Seeking Alpha PRO for equity research that is unavailable elsewhere, so they can: